cbdMD, Inc.YCBDNYSE
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P50
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
2025-7.34%
2024-37.08%
2023-41.01%
2022-22.17%
202110.54%
202052.21%
20191396.43%
2018-42.55%
2017-18.99%
20160.00%